News and blogs
162 results found.
Meet the Scientists 2019 - highlights
The event showcases recent breakthroughs in blood cancer research. It's an opportunity to hear about the latest updates in treatments and technologies.
Targeting multiple cancer genes could be key to treating leukaemia
Faults in two genes directly work together to bring about the deadliest form of blood cancer, scientists have discovered in a study that could pave the way for better treatments.
How genomics help people with blood cancer?
What is genomics exactly, and how will it help people with blood cancer now and in the future? Blood Cancer UK's Dr Ross P. Coron explains all.
Blood cancer documentary gave me hope.
War in the Blood, a new BBC documentary follows two people who received CAR-T therapy, a groundbreaking new treatment for blood cancer, as part of a clinical trial. Kate, our Senior Support Services Manager, reviews the documentary.
Blood cancer survival beating other cancers
New analysis shows survival rates for blood cancer have risen faster than for other common cancers in recent years. Find out more.
Researchers grow blood stem cells in lab
A method of growing blood stem cells in the laboratory has been developed by researchers at Stanford University and the University of Tokyo.
Blood cancer and how to cope with stress
For Mental Health Awareness Week, two Bloodwise-funded researchers share things they do to try to maintain mental wellbeing in a stressful environment.
This week I’ve analysed 18,000 genes!
We spoke to Dr Amir Enshaei to find out how his research will reduce the long-term side effects of treatment for children with blood cancer.
Discovery could treat childhood blood cancers
Genetic mutations that drive the development of childhood leukaemia can be traced to errors by the immune system during the production of antibodies.
Leukaemia treatment: test could predict response
The first test to quickly and accurately predict how people will respond to standard treatment for the most common type of leukaemia has been developed.
CAR-T access in Scotland for childhood leukaemia
Children and young people in Scotland with ALL who relapse after standard treatments will be able to access the CAR-T cell therapy Kymriah.
Two breakthroughs in CAR-T therapy
First child with acute lymphoblastic leukaemia (ALL) receives CAR-T therapy on the NHS and the treatment is made available to adult lymphoma patients.
How a virus can lead to lymphoma trial
Our researcher has been investigating how a virus that causes lymphoma increases the production of this cancer-driving microRNA. Find out more.
Blood Cancer UK research highlights 2018
From CAR-T therapy to a new understanding of how leukaemia develops in children. We look back at some of the breakthroughs our supporters help us fund.
How gene mutations cause blood cancers
Blood Cancer UK scientists at the University of Birmingham have revealed the roles that different types of gene mutations play in causing blood cancers.
New leukaemia treatment in Scotland
A targeted drug that improves survival for people with an aggressive type of blood cancer will be made available on the NHS in Scotland.
CAR-T therapies hold promise for cancers
Immunotherapy treatments called CAR-T therapies involve reprogramming a type of ‘supercharged’ immune cell could be mass-produced to help fight cancer.
Through the eye of a needle: Molecular immunology and anti-cancer drugs
Finding drugs that can target cancer cells but leave healthy cells unharmed is an ongoing problem in cancer research. At the University of Oxford, Professor Terry Rabbitts is exploring ways to create targeted drugs that work by blocking blood cancer proteins from interacting with healthy proteins – and the technique he’s developed for making these drugs could also have an impact on many other diseases. Read on to find out more…
CAR-T treatment turned down on NHS
The NHS medicines watchdog has recommended that a treatment called Kymriah should not be available to people with diffuse large B-cell lymphoma (DLBCL).